(Page 9)

July 28, 2020 U.S. News & World Report: UVA Again No. 1 Hospital in Virginia

It's the fifth consecutive year. The publication also ranks eight UVA specialties among the best in the nation.

July 21, 2020 Quality Heart and Lung Care Earns UVA International Award

Fewer than 30 hospitals worldwide have earned the award.

June 30, 2020 Exercise Can Slow or Prevent Vision Loss, Study Finds

A new study found that exercise reduced the harmful overgrowth of blood vessels in the eyes of lab mice by up to 45%. This tangle of blood vessels is a key contributor to macular degeneration and other eye diseases.

June 24, 2020 Fire Ants Limiting Spread of Meat Allergy – But Pose Own Danger

Invasive fire ants are limiting the spread of a dangerous meat allergy. But it’s not all good news: The ants can also cause severe allergic reactions.

June 10, 2020 UVA Health Expanding Food Allergy Research, Clinical Trials

UVA Health and UVA Children’s are increasing access to the latest food allergy clinical trials and expanding their cutting-edge food-allergy research.

May 29, 2020 Obesity Makes COVID-19 Harder to Fight

A doctor offers seven important tips for managing obesity.

May 4, 2020 UVA Health Trial to Test Convalescent Plasma as Potential COVID-19 Treatment

UVA Health is testing the use of plasma from patients who have recovered from COVID-19 as a potential treatment for inpatients with the disease.

March 3, 2020 Artificial Pancreas Up for Best Biomedical Advance in STAT Madness Bracket Challenge

A UVA Health-developed artificial pancreas system is among the nominees for 2019’s best biomedical research and is fighting to win…

January 2, 2020 FDA Approves UVA-Developed Artificial Pancreas

The U.S. Food and Drug Administration has approved an artificial pancreas system – based on technology from the University of…

December 19, 2019 UVA Center for Diabetes Technology and Novo Nordisk Enter Into Research Collaboration to Develop Virtual Patient Modelling for Type 2 Diabetes

University of Virginia (UVA) Center for Diabetes Technology and Novo Nordisk today announced that they have entered into a five-year research collaboration where UVA and Novo Nordisk will work together on the development of virtual environments focused on modelling of patients with type 2 diabetes.